Business Seminar with GlaxoSmithkline Ltd.

      
     

The British Chamber of Commerce in Hungary

in association with

GlaxoSmithKline Ltd.,

the American Chamber of Commerce in Hungary
and the German-Hungarian Chamber of Commerce and Industry

held a Business Seminar followed by a reception on

How to maintain business continuity
during the upcoming waves of the A/H1N1 pandemic

on Tuesday, 2 March 2010, 17:30 at the Budapest Marriott Hotel.

Speakers and topics

Moderator:
Dr. Klára Marton, Director of Vaccine Unit, GlaxoSmithKline Ltd.


Dr. Zsófia Pusztai, Head of WHO Country Office for Hungary
• WHO review of 1st H1N1 pandemic wave
• Upcoming pandemic waves until 2011
• WHO’s recommendations and guidelines for pandemic preparation for companies


Dr. László Bujdosó, Chairman of the Hungarian Pandemic Committee
Preparation for upcoming pandemic waves
• Summary of the European and Hungarian pandemic situation, key learnings of the 1st H1N1 pandemic wave
• Human effects of upcoming pandemic waves
• Hungarian Pandemic Board recommandations for companies regarding pandemic preparedness


László Skultéty, General Manager, GKI-EKI HealthCare Research Institute
• Economic effects of the H1N1 pandemic globally and in Hungary
• Economic impact of the upcoming 2nd and 3rd waves until 2011


Tibor Lados, HR Director, Matra Power Plant
Practical experience on pandemic preparation
• Pandemic preparation actions and communication - what was the approach and goal of the management?
• What kind of vaccines, antiviral drugs, antibiotics and masks were procured? What was used up? How did the employees react?
• Epidemic experience